(Q36257688)

English

Prospects for a group A streptococcal vaccine: rationale, feasibility, and obstacles--report of a National Institute of Allergy and Infectious Diseases workshop.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163634%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Prospects for a group A streptococcal vaccine: rationale, feasibility, and obstacles--report of a National Institute of Allergy and Infectious Diseases workshop (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163634%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

0 references

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163634%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

Alan L Bisno

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163634%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Fran A Rubin

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163634%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

P Patrick Cleary

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163634%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

National Institute of Allergy and Infectious Diseases

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163634%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

language of work or name

0 references

publication date

2 September 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163634%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163634%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

41

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163634%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163634%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1150-1156

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163634%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Acute pharyngitis

1 reference

https://api.crossref.org/works/10.1086%2F444505

21 January 2018

Rheumatic Fever in children under 5 years

1 reference

https://api.crossref.org/works/10.1086%2F444505

21 January 2018

Respiratory diseases among U.S. military personnel: countering emerging threats

1 reference

https://api.crossref.org/works/10.1086%2F444505

21 January 2018

Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999.

1 reference

https://api.crossref.org/works/10.1086%2F444505

21 January 2018

Genetic correlates of throat and skin isolates of group A streptococci

1 reference

https://api.crossref.org/works/10.1086%2F444505

21 January 2018

New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population.

1 reference

https://api.crossref.org/works/10.1086%2F444505

21 January 2018

Vaccination with streptococcal extracellular cysteine protease (interleukin-1β convertase) protects mice against challenge with heterologous group A streptococci

1 reference

https://api.crossref.org/works/10.1086%2F444505

21 January 2018

New protective antigen of group A streptococci

1 reference

https://api.crossref.org/works/10.1086%2F444505

21 January 2018

Identification of new candidate vaccine antigens made by Streptococcus pyogenes: purification and characterization of 16 putative extracellular lipoproteins

1 reference

https://api.crossref.org/works/10.1086%2F444505

21 January 2018

Intranasal immunization with multivalent group A streptococcal vaccines protects mice against intranasal challenge infections.

1 reference

https://api.crossref.org/works/10.1086%2F444505

21 January 2018

Pathogenesis of group A streptococcal infections

1 reference

https://api.crossref.org/works/10.1086%2F444505

21 January 2018

Molecular basis of group A streptococcal virulence

1 reference

https://api.crossref.org/works/10.1086%2F444505

21 January 2018

Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis

1 reference

https://api.crossref.org/works/10.1086%2F444505

21 January 2018

Toxoids of streptococcal pyrogenic exotoxin A are protective in rabbit models of streptococcal toxic shock syndrome.

1 reference

https://api.crossref.org/works/10.1086%2F444505

21 January 2018

HLA class II associations with rheumatic heart disease are more evident and consistent among clinically homogeneous patients

1 reference

https://api.crossref.org/works/10.1086%2F444505

21 January 2018

Intravenous Immunoglobulin Adjunctive Therapy in Sepsis, with Special Emphasis on Severe Invasive Group A Streptococcal Infections

1 reference

https://api.crossref.org/works/10.1086%2F444505

21 January 2018

STUDIES ON THE BIOLOGY OF STREPTOCOCCUS : I. ANTIGENIC RELATIONSHIPS BETWEEN STRAINS OF STREPTOCOCCUS HAEMOLYTICUS

1 reference

https://api.crossref.org/works/10.1086%2F444505

21 January 2018

Protective Studies with a Group A Streptococcal M Protein Vaccine. II. Challenge of Volunteers after Local Immunization in the Upper Respiratory Tract

1 reference

https://api.crossref.org/works/10.1086%2F444505

21 January 2018

Human immune response to immunization with a structurally defined polypeptide fragment of streptococcal M protein

1 reference

https://api.crossref.org/works/10.1086%2F444505

21 January 2018

Immunization with C5a peptidase or peptidase-type III polysaccharide conjugate vaccines enhances clearance of group B Streptococci from lungs of infected mice

1 reference

https://api.crossref.org/works/10.1086%2F444505

21 January 2018

Protection against group A streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protection

1 reference

https://api.crossref.org/works/10.1086%2F444505

21 January 2018

Clinical and microbiological responses of volunteers to combined intranasal and oral inoculation with a Streptococcus gordonii carrier strain intended for future use as a group A streptococcus vaccine

1 reference

https://api.crossref.org/works/10.1086%2F444505

21 January 2018

Group A streptococcal vaccines

1 reference

https://api.crossref.org/works/10.1086%2F444505

21 January 2018

Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers

1 reference

https://api.crossref.org/works/10.1086%2F444505

21 January 2018

Epidemiologic analysis of invasive and noninvasive group a streptococcal isolates in Hong Kong

1 reference

https://api.crossref.org/works/10.1086%2F444505

21 January 2018

Variable susceptibility to opsonophagocytosis of group A streptococcus M-1 strains by human immune sera.

1 reference

https://api.crossref.org/works/10.1086%2F444505

21 January 2018

Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes

1 reference

https://api.crossref.org/works/10.1086%2F444505

21 January 2018

An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections

1 reference

https://api.crossref.org/works/10.1086%2F444505

21 January 2018

Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial

1 reference

https://api.crossref.org/works/10.1086%2F444505

21 January 2018

Protective Immune Response againstStreptococcus pyogenesin Mice after Intranasal Vaccination with the Fibronectin‐Binding Protein SfbI

1 reference

https://api.crossref.org/works/10.1086%2F444505

21 January 2018

Intranasal Immunization with Recombinant Group A Streptococcal M Protein Fragment Fused to the B Subunit of Escherichia coli Labile Toxin Protects Mice against Systemic Challenge Infections

1 reference

https://api.crossref.org/works/10.1086%2F444505

21 January 2018

Group A Streptococcal Pharyngitis Serotype Surveillance in North America, 2000–2002

1 reference

https://api.crossref.org/works/10.1086%2F444505

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36257688&oldid=1519996939"